Report Library
View More
Systemic Lupus Erythematosus KOL In...
December 26, 2025
Systemic Lupus Erythematosus KOL In...
December 25, 2025
2025 Biomedtracker Datamonitor Post...
December 24, 2025
Biomedtracker and Meddevicetracker'...
December 24, 2025
Schizophrenia KOL US, Eastcoast #2
December 24, 2025
Schizophrenia KOL US, Eastcoast #1
December 24, 2025
Datamonitor Healthcare I&I Disease ...
December 23, 2025
Datamonitor Healthcare CNS Disease ...
December 21, 2025
Podcast: A Deep Dive into Dry AMD
December 19, 2025
Datamonitor Healthcare CNS Disease ...
December 11, 2025
Datamonitor Healthcare CV&Met Disea...
December 11, 2025
Datamonitor Healthcare CNS: Fibromy...
December 10, 2025
Datamonitor Healthcare Oncology: Sa...
December 10, 2025
Datamonitor Healthcare Oncology Dis...
December 5, 2025
Amyotrophic Lateral Sclerosis (ALS)...
December 4, 2025
Datamonitor Healthcare Other: Benig...
December 4, 2025
Datamonitor Healthcare Other: Endom...
December 4, 2025
Datamonitor Healthcare CNS: Hunting...
December 4, 2025
Datamonitor Healthcare Oncology Dis...
December 2, 2025
Datamonitor Healthcare Oncology Dis...
December 2, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 12/12/25 | Johnson & Johnson (JNJ) | Tecvayli for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/11/25 | Azura Ophthalmics | AZR-MD-001 for Dry Eye (Ophthalmology) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/9/25 | Terns Pharmaceuticals (TERN) | TERN-701 for Chronic Myelogenous Leukemia (CML) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/9/25 | Geron (GERN) | Rytelo for Myelodysplastic Syndrome (MDS) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/9/25 | Nurix Therapeutics (NRIX) | bexobrutideg for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/30/2025 | Subscribers Only | Subscribers Only | Trial Announcement - Patient Enrollment Completed |
| 01/01/2026 - 06/30/2025 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |